Anti-BAP1 monoclonal antibody

Pre-made anti-BAP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to BAP1/BAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T92628-Ab-1/ GM-Tg-hg-T92628-Ab-2Anti-Human BAP1 monoclonal antibodyHuman
GM-Tg-rg-T92628-Ab-1/ GM-Tg-rg-T92628-Ab-2Anti-Rat BAP1 monoclonal antibodyRat
GM-Tg-mg-T92628-Ab-1/ GM-Tg-mg-T92628-Ab-2Anti-Mouse BAP1 monoclonal antibodyMouse
GM-Tg-cynog-T92628-Ab-1/ GM-Tg-cynog-T92628-Ab-2Anti-Cynomolgus/ Rhesus macaque BAP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T92628-Ab-1/ GM-Tg-felg-T92628-Ab-2Anti-Feline BAP1 monoclonal antibodyFeline
GM-Tg-cang-T92628-Ab-1/ GM-Tg-cang-T92628-Ab-2Anti-Canine BAP1 monoclonal antibodyCanine
GM-Tg-bovg-T92628-Ab-1/ GM-Tg-bovg-T92628-Ab-2Anti-Bovine BAP1 monoclonal antibodyBovine
GM-Tg-equg-T92628-Ab-1/ GM-Tg-equg-T92628-Ab-2Anti-Equine BAP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T92628-Ab-1/ GM-Tg-hg-T92628-Ab-2; GM-Tg-rg-T92628-Ab-1/ GM-Tg-rg-T92628-Ab-2;
GM-Tg-mg-T92628-Ab-1/ GM-Tg-mg-T92628-Ab-2; GM-Tg-cynog-T92628-Ab-1/ GM-Tg-cynog-T92628-Ab-2;
GM-Tg-felg-T92628-Ab-1/ GM-Tg-felg-T92628-Ab-2; GM-Tg-cang-T92628-Ab-1/ GM-Tg-cang-T92628-Ab-2;
GM-Tg-bovg-T92628-Ab-1/ GM-Tg-bovg-T92628-Ab-2; GM-Tg-equg-T92628-Ab-1/ GM-Tg-equg-T92628-Ab-2
Products NameAnti-BAP1 monoclonal antibody
Formatmab
Target NameBAP1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-BAP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T92628-Ag-1Recombinant multi-species BAP1/ HUCEP-13/ UCHL2 protein
    ORF Viral VectorpGMLPm003594mouse Bap1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003594mouse Bap1 Lentivirus particle


    Target information

    Target IDGM-T92628
    Target NameBAP1
    Gene ID8314,104416,306257,697221,484737,101092671,100124510,100051934
    Gene Symbol and Synonyms2300006C11Rik,BAP1,HUCEP-13,hucep-6,KURIS,mKIAA0272,TPDS1,UBM2,uch-x4,UCHL2,UVM2
    Uniprot AccessionQ92560,D3ZHS6,A2VDM8
    Uniprot Entry NameBAP1_HUMAN,BAP1_RAT,BAP1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000163930
    Target ClassificationTumor-associated antigen (TAA)

    The target: BAP1, gene name: BAP1, also named as HUCEP-13, UCHL2, hucep-6. This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma. [provided by RefSeq, May 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.